東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Characterization of UBIAD1 and its r...

Nickerson, Michael L.

Linked to FindBook

Google Book

Amazon

博客來

Characterization of UBIAD1 and its role in Schnyder corneal dystrophy.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Characterization of UBIAD1 and its role in Schnyder corneal dystrophy./
Author:	Nickerson, Michael L.
Description:	148 p.
Notes:	Source: Dissertation Abstracts International, Volume: 71-11, Section: B, page: 6541.
Contained By:	Dissertation Abstracts International71-11B.
Subject:	Biology, Molecular. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3422895
ISBN:	9781124227689

Characterization of UBIAD1 and its role in Schnyder corneal dystrophy.
Nickerson, Michael L.

Characterization of UBIAD1 and its role in Schnyder corneal dystrophy. - 148 p.

Source: Dissertation Abstracts International, Volume: 71-11, Section: B, page: 6541.

Thesis (Ph.D.)--The George Washington University, 2011.

Schnyder corneal dystrophy (SCD) is an inherited, autosomal dominant eye disease first described in 1924. Mutations in a novel gene, UBIAD1, were recently found to cause SCD. SCD is characterized by an abnormal deposition of cholesterol and phospholipids in the cornea, resulting in progressive corneal opacification and visual loss. We characterized UBIAD1 alterations in ten new SCD families, including five novel mutations, A97T, D112N, V122E, V122G, and L188H. A V122E mutation was observed in a first SCD family of Native American ethnicity. Examination of protein homology revealed that SCD altered amino acids that were highly conserved across species. Immunohistochemistry on keratocyte cell lines established after corneal transplant surgery using antibodies specific for UBIAD1 established a subcellular localization to mitochondria of N102S mutant and wild-type protein. Cell line extracts of peripheral blood mononuclear cells immortalized using Epstein-Barr virus were used to examine levels of total cholesterol, cholesteryl ester, and unesterified cholesterol. A fluorometric assay showed no significant alteration in cellular amounts of these molecules relative to non-SCD cell lysates. Molecular modeling was used to examine membrane protein structure, binding of potential ligands, and the effect(s) of SCD mutations. A membrane protein with eight helices was observed, with five residues altered in SCD predicted to lie near the primary active site: A97, N102, D112, V122, and L188. Substrate docking simulations showed active site binding of geranyl- and farnesylpyrophosphates. Prenyl substrates with longer fatty acid tails were docked and predicted to be stabilized by hydrogen bonds with SCD mutant residue, N102, and R235. Though not altered in SCD, R235 appeared to be stabilized by neighboring SCD mutant residues: N232, N233, and D236. A potential secondary substrate binding site for aromatic/phenol molecules was identified based upon homology between UBIAD1 and octaprenyltransferases. Docking simulations predicted that both prenyl and aromatic molecules could bind to an interior cleft or groove leading to N102 near the primary active site. Substrate docking simulations with in silico mutant UBIAD1 revealed that aromatic substrates were no longer recognized by N102 upon mutation to a serine. Accumulating evidence from the SCD familial mutation spectrum, protein homology across species, and molecular modeling suggest protein function is impaired due to SCD mutation.Mitochondrial UBIAD1 protein appears to have a highly conserved function that, in humans, may be involved in cholesterol metabolism in a novel manner.

ISBN: 9781124227689Subjects--Topical Terms:

1017719
Biology, Molecular.

Characterization of UBIAD1 and its role in Schnyder corneal dystrophy.
LDR:03824nam 2200349 4500 001 1405490
005 20111219143036.5
008 130515s2011 ||||||||||||||||| ||eng d
020 $a 9781124227689
035 $a (UMI)AAI3422895
035 $a AAI3422895
040 $a UMI $c UMI
100 1 $a Nickerson, Michael L. $3 1684856
245 1 0 $a Characterization of UBIAD1 and its role in Schnyder corneal dystrophy.
300 $a 148 p.
500 $a Source: Dissertation Abstracts International, Volume: 71-11, Section: B, page: 6541.
500 $a Advisers: Michael Dean; Mary Ann Stepp.
502 $a Thesis (Ph.D.)--The George Washington University, 2011.
520 $a Schnyder corneal dystrophy (SCD) is an inherited, autosomal dominant eye disease first described in 1924. Mutations in a novel gene, UBIAD1, were recently found to cause SCD. SCD is characterized by an abnormal deposition of cholesterol and phospholipids in the cornea, resulting in progressive corneal opacification and visual loss. We characterized UBIAD1 alterations in ten new SCD families, including five novel mutations, A97T, D112N, V122E, V122G, and L188H. A V122E mutation was observed in a first SCD family of Native American ethnicity. Examination of protein homology revealed that SCD altered amino acids that were highly conserved across species. Immunohistochemistry on keratocyte cell lines established after corneal transplant surgery using antibodies specific for UBIAD1 established a subcellular localization to mitochondria of N102S mutant and wild-type protein. Cell line extracts of peripheral blood mononuclear cells immortalized using Epstein-Barr virus were used to examine levels of total cholesterol, cholesteryl ester, and unesterified cholesterol. A fluorometric assay showed no significant alteration in cellular amounts of these molecules relative to non-SCD cell lysates. Molecular modeling was used to examine membrane protein structure, binding of potential ligands, and the effect(s) of SCD mutations. A membrane protein with eight helices was observed, with five residues altered in SCD predicted to lie near the primary active site: A97, N102, D112, V122, and L188. Substrate docking simulations showed active site binding of geranyl- and farnesylpyrophosphates. Prenyl substrates with longer fatty acid tails were docked and predicted to be stabilized by hydrogen bonds with SCD mutant residue, N102, and R235. Though not altered in SCD, R235 appeared to be stabilized by neighboring SCD mutant residues: N232, N233, and D236. A potential secondary substrate binding site for aromatic/phenol molecules was identified based upon homology between UBIAD1 and octaprenyltransferases. Docking simulations predicted that both prenyl and aromatic molecules could bind to an interior cleft or groove leading to N102 near the primary active site. Substrate docking simulations with in silico mutant UBIAD1 revealed that aromatic substrates were no longer recognized by N102 upon mutation to a serine. Accumulating evidence from the SCD familial mutation spectrum, protein homology across species, and molecular modeling suggest protein function is impaired due to SCD mutation.Mitochondrial UBIAD1 protein appears to have a highly conserved function that, in humans, may be involved in cholesterol metabolism in a novel manner.
590 $a School code: 0075.
650 4 $a Biology, Molecular. $3 1017719
650 4 $a Biology, Genetics. $3 1017730
650 4 $a Health Sciences, Ophthalmology. $3 1019445
690 $a 0307
690 $a 0369
690 $a 0381
710 2 $a The George Washington University. $b Biomedical Sciences. $3 1682759
773 0 $t Dissertation Abstracts International $g 71-11B.
790 1 0 $a Dean, Michael, $e advisor
790 1 0 $a Stepp, Mary Ann, $e advisor
790 1 0 $a Lee, Norman H. $e committee member
790 1 0 $a Schwartz, Arnold M. $e committee member
790 1 0 $a Zbar, Berton $e committee member
790 1 0 $a Leitenberg, David $e committee member
790 $a 0075
791 $a Ph.D.
792 $a 2011
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3422895